HIV Mortality and Associated Factors in Patients Admitted at a Tertiary-care Hospital in Uganda, A Cross-sectional Study

Author:

Owachi Darius1,Akatukunda Praise2,Nanyanzi Diana Sarah2,Katwesigye Rogers2,Wanyina Shardrack2,Muddu Martin2,Kawuma Samuel2,Kalema Nelson3,Kabugo Charles1,Semitala Fred C.2

Affiliation:

1. Kiruddu National Referral Hospital

2. Makerere University Joint AIDS Program

3. Infectious Diseases Institute

Abstract

Abstract Background: Outcomes for Persons living with HIV (PLHIV) admitted to hospitals in Uganda are relatively unknown. We determined the prevalence of mortality and associated factors in PLHIV admitted at a tertiary-level public hospital in Uganda. Methods: We used routinely collected data for PLHIV admitted at Kiruddu National Referral Hospital (KNRH) from March 2020 to March 2023 to perform a cross-sectional analysis for mortality (using proportions) and associated factors using a logistic regression model. Results: Of the 5,827 PLHIV admitted, 3293 (56.51%) were female and the median age was 39 years (interquartile range [IQR] 31-49, range 12-98). CD4+ cell count was documented in 3,715 (63.75%) admitted PLHIV with a median count of 109 cells/µL (IQR 25-343, range 0-1,475). At admission, 3,710 (63.67%) were actively taking their antiretroviral therapy (ART), 1,144 (19.63%) had interrupted ART for more than three months and 973 (16.70%) were not on ART. Functional status impairment (measured using Eastern Cooperative Oncology Group [ECOG] score 3-4) was observed in 2,225 (38.18%) PLHIV. Overall mortality was 26% (1,524) with a median time-to-death of 3 days (IQR 1-7, range 0-88). Factors associated with mortality included Function impairment odds ratio 7.23 (95%CI 6.31-8.29; undocumented CD4+ cell count 1.53 (95%CI 1.33-1.76, P<0.001); distance >20 Km from hospital 1.21 (95%CI 1.03-1.43, P=0.024); ART interruption 1.34 (95%CI 1.14-1.59; P<0.001); being male 1.16 (95%CI 1.02-1.32, P=0.029); severe malnutrition 1.81 (95%CI 1.51-2.16; P<0.001); COVID19 disease 1.74 (95%CI 1.24-2.43; P=0.001); liver disease 1.75 (95%CI 1.35-2.28; P<0.001); kidney disease 1.64 (95%CI 1.31-2.05; P<0.001); non-opportunistic infections 1.52 (95%CI 1.30-1.77, P<0.001); and anaemia 1.25 (95%CI 1.02-1.54, P=0.034). Conclusion: One in every four admitted PLHIV died during hospitalization. Early identification and management of associated risk factors such as ART interruption, function impairment, baseline CD4+ tests and screening for non-communicable diseases, may avert poor hospital outcomes.

Publisher

Research Square Platform LLC

Reference67 articles.

1. UNAIDS, Global HIV. & AIDS statistics — Fact sheet | UNAIDS [Internet]. 2021 [cited 2021 Dec 31]. Available from: https://www.unaids.org/en/resources/fact-sheet.

2. UNAIDS. Uganda | UNAIDS [Internet]. 2021 [cited 2022 Jan 1]. Available from: https://www.unaids.org/en/regionscountries/countries/uganda.

3. Laher AE, Paruk F, Venter WDF, Ayeni OA, Richards GA. Predictors of in-hospital mortality among HIV-positive patients presenting with an acute illness to the emergency department. HIV Med [Internet]. 2021 Aug 1 [cited 2021 Dec 31];22(7):557–66. Available from: https://pubmed.ncbi.nlm.nih.gov/33792151/.

4. Kalyesubula Id R, Id TR, Andia-Biraro I, Alupo P, Kimuli I, Nabirye S et al. Trends of admissions and case fatality rates among medical in-patients at a tertiary hospital in Uganda; A four-year retrospective study. 2019; https://doi.org/10.1371/journal.pone.0216060.

5. Lakoh S, Jiba DF, Kanu JE, Poveda E, Salgado-Barreira A, Sahr F et al. Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra Leone: a prospective study. BMC Public Health [Internet]. 2019 Oct 21 [cited 2021 Dec 31];19(1). Available from: https://pubmed.ncbi.nlm.nih.gov/31638941/.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3